April Betts is a seasoned Market Access and Health Economics professional with experience in pharmaceuticals and medical devices across various therapy areas, including immunology, neurology, diabetes, and rare diseases. They led successful HTA submissions, notably for UrgoStart at Urgo Medical, and managed multiple stakeholders during HTA processes at The Manchester Metropolitan University. Having achieved a PhD in Health Economics and Health Policy from The Manchester Metropolitan University, they currently hold a position with UCB as a Global Health Economics and HTA Evidence Lead.
This person is not in any teams
This person is not in any offices